{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:32:39Z","timestamp":1790778759169,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cgh.2017.02.016","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T02:30:33Z","timestamp":1487903433000},"page":"1557-1564.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"title":["Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-4275","authenticated-orcid":false,"given":"Britt","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Hanauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1467-7330","authenticated-orcid":false,"given":"Jonathan","family":"Erlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-2332","authenticated-orcid":false,"given":"Olufemi","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-2462","authenticated-orcid":false,"given":"John","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.02.016_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A\u00a0review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","article-title":"Biopsy studies in ulcerative colitis","volume":"1","author":"Truelove","year":"1956","journal-title":"Br Med J"},{"key":"10.1016\/j.cgh.2017.02.016_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Froslie","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","article-title":"Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis","volume":"141","author":"Colombel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2009.06.061","article-title":"Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab","volume":"137","author":"Sandborn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1572-0241.2007.01094.x","article-title":"The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients","volume":"102","author":"Feagan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.016_bib8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.016_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/ajg.2012.301","article-title":"Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing","volume":"107","author":"Bessissow","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.016_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","article-title":"Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis","volume":"120","author":"Bitton","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib12","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/ajg.2016.418","article-title":"Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis","volume":"111","author":"Park","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.016_bib13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.02.016_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/DCR.0b013e31819ad456","article-title":"Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis","volume":"52","author":"Hefti","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2017.02.016_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","article-title":"Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up","volume":"65","author":"Bryant","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cgh.2013.07.022","article-title":"Histologic remission: the ultimate therapeutic goal in ulcerative colitis?","volume":"12","author":"Peyrin\u2013Biroulet","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.02.016_bib18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/MIB.0b013e318281f4ae","article-title":"Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission","volume":"18","author":"Feagins","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2017.02.016_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A\u00a0reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"Marchal-Bressenot","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00000478-199309000-00002","article-title":"Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis","volume":"17","author":"Odze","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2017.02.016_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib24","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ajg.2009.83","article-title":"Safety and efficacy of a new 3.3 g bid tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo- controlled study","volume":"104","author":"Scherl","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.016_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A\u00a0simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.016_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00000478-199808000-00008","article-title":"Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time","volume":"22","author":"Kleer","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2017.02.016_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jcp.49.4.319","article-title":"Diagnostic difficulty arising from rectal recovery in ulcerative colitis","volume":"49","author":"Levine","year":"1996","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cgh.2017.02.016_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0016-5107(95)70097-8","article-title":"Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study","volume":"42","author":"Bernstein","year":"1995","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2017.02.016_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.016_bib30","unstructured":"U.S. Department of Health and Human Services Food and Drug Adminstration Center for Drug Evaluation and Research (CDER).\u00a0Ulcerative colitis: clinical trial endpoints guidance for\u00a0industry. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm515143.pdf. Accessed September 4,\u00a02016."},{"key":"10.1016\/j.cgh.2017.02.016_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(14)60817-9","article-title":"Assessment of the degree of variation of histologic inflammation in ulcerative colitis","volume":"146","author":"Mikolajczyk","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.016_bib32","first-page":"1188","article-title":"Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial","volume":"88","author":"Hanauer","year":"1993","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517301969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517301969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:22:54Z","timestamp":1761542574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517301969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1542356517301969"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.02.016","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}